WO2013/104804 was filed by the University of Würzburg and is granted in Europe, China, Japan and Mexico with a very broad scope of protection. Cherry biolabs holds the exclusive license with the
right to sublicense.
Published: 26 November 2019
“On-target restoration of a split T cell-engaging antibody for precision immunotherapy”